{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:42:57Z","timestamp":1787312577295,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.diabres.2019.01.035","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T03:05:47Z","timestamp":1550113547000},"page":"331-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial"],"prefix":"10.1016","volume":"150","author":[{"given":"Mohamed M.","family":"Hassanein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-4336","authenticated-orcid":false,"given":"Khadija","family":"Hafidh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khier","family":"Djaballah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-7080","authenticated-orcid":false,"given":"Sami","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Shehadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2019.01.035_b0005","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/diacare.27.10.2306","article-title":"A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422\/2001 (EPIDIAR) study","volume":"27","author":"Salti","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.01.035_b0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/dme.12685","article-title":"Multi-country retrospective observational study of the management and outcomes of patients with type 2 diabetes during Ramadan in 2010 (CREED)","volume":"32","author":"Babineaux","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2019.01.035_b0015","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/dc10-0896","article-title":"Recommendations for management of diabetes during Ramadan: update 2010","volume":"33","author":"Al-Arouj","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.01.035_b0020","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1185\/03007995.2011.578245","article-title":"Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study","volume":"27","author":"Aravind","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2019.01.035_b0025","first-page":"766","article-title":"Effect of Ramadan fasting on glycemic control in patients with type 2 diabetes","volume":"35","author":"Norouzy","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.diabres.2019.01.035_b0030","first-page":"1858","article-title":"Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake","volume":"25","author":"Khatib","year":"2004","journal-title":"Saudi Med J"},{"key":"10.1016\/j.diabres.2019.01.035_b0035","first-page":"329","article-title":"Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes","volume":"13","author":"Yarahmadi","year":"2003","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.diabres.2019.01.035_b0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10641960802272442","article-title":"Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?","volume":"30","author":"M'Guil","year":"2008","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.diabres.2019.01.035_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.diabres.2005.10.028","article-title":"Diabetes and Ramadan: review of the literature","volume":"73","author":"Benaji","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2019.01.035_b0050","first-page":"732","article-title":"Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control","volume":"67","author":"Laajam","year":"1990","journal-title":"East Afr Med J"},{"key":"10.1016\/j.diabres.2019.01.035_b0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-0033-1347247","article-title":"The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus","volume":"121","author":"Sahin","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.diabres.2019.01.035_b0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.diabet.2014.11.004","article-title":"Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM)","volume":"41","author":"Lessan","year":"2015","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2019.01.035_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diabres.2017.03.003","article-title":"Diabetes and Ramadan: practical guidelines","volume":"126","author":"Hassanein","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2019.01.035_b0070","first-page":"774","article-title":"South Asian consensus guideline: Use of GLP-1 receptor agonists during Ramadan: Update 2016 Revised Guidelines on the use of GLP-1A in Ramadan","volume":"66","author":"Pathan","year":"2016","journal-title":"J Pak Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2019.01.035_b0075","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.2337\/dcS13-2011","article-title":"Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes","volume":"36","author":"DeFronzo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.01.035_b0080","unstructured":"Lyxumia. Summary of product characteristics; 2014. Available from: <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002445\/WC500140401.pdf> [accessed November 5, 2018]."},{"key":"10.1016\/j.diabres.2019.01.035_b9000","unstructured":"CONSORT. Consolidated Standards of Reporting Trials; 2010. Available from: http:\/\/www.consort-statement.org\/ [accessed February 27, 2019]"},{"key":"10.1016\/j.diabres.2019.01.035_b0085","unstructured":"International Diabetes Federation (IDF) in collaboration with the Diabetes and Ramadan (DAR) International Alliance. Diabetes and Ramadan: Practical Guidelines; 2016. Available from: <www.idf.org\/guidelines\/diabetes-in-ramadan> [accessed November 5, 2018]."},{"key":"10.1016\/j.diabres.2019.01.035_b0090","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2019.01.035_b0095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4172\/2155-6156.1000590","article-title":"Safety and efficacy of liraglutide as an add-on therapy to pre-existing anti-diabetic regimens during Ramadan, a prospective observational trial","volume":"6","author":"Khalifa","year":"2015","journal-title":"J Diabetes Metab"},{"key":"10.1016\/j.diabres.2019.01.035_b0100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1464-5491.2009.02836.x","article-title":"Efficacy and safety of insulin glargine and glimepiride in subjects with type 2 diabetes before, during and after the period of fasting in Ramadan","volume":"26","author":"Salti","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2019.01.035_b0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/ijem.IJEM_556_17","article-title":"Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of type 2 diabetes mellitus - International Task Force","volume":"22","author":"Kalra","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2019.01.035_b0110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/ijcp.12243","article-title":"The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study","volume":"67","author":"Al-Arouj","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2019.01.035_b0115","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1742-1241.2011.02797.x","article-title":"The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial","volume":"65","author":"Al Sifri","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2019.01.035_b0120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.diabres.2019.01.035_b0125","doi-asserted-by":"crossref","first-page":"e000108","DOI":"10.1136\/bmjdrc-2015-000108","article-title":"Recommendations for management of diabetes during Ramadan: update 2015","volume":"3","author":"Ibrahim","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2019.01.035_b0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1464-5491.2010.02948.x","article-title":"Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with type 2 diabetes who fast during Ramadan","volume":"27","author":"Bravis","year":"2010","journal-title":"Diabet Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719300129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719300129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:09:59Z","timestamp":1759172999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719300129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"alternative-id":["S0168822719300129"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2019.01.035","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2019.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}